Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondria-targeted metformin analogs activate the ER stress-unfolded protein response pathway to drive apoptosis in pancreatic cancer.

Cell death & disease·2026
Same author

A soft diet attenuates exercise-induced increases in cortical bone density and formation in long bones in growing mice.

Scientific reports·2026
Same author

ZO-1 shuttles between apical junctional complexes and podosomes by riding ERK activation waves.

Nature communications·2026
Same author

Two closely related β-1,2-xylosyltransferases differentially impact fungal glycan synthesis.

bioRxiv : the preprint server for biology·2026
Same author

Localized heat induces ERK activation and signal propagation in solid tumors.

Scientific reports·2026
Same author

Metabolic Response to CDK4/6 Inhibition in ER+ Breast Cancer Creates a Therapeutic Vulnerability in Drug-Tolerant Persister Cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Related Experiment Video

Updated: Jul 11, 2026

Mass Spectrometric Analysis of Glycosphingolipid Antigens
13:09

Mass Spectrometric Analysis of Glycosphingolipid Antigens

Published on: April 16, 2013

16.5K

DANGO: An MS data annotation tool for glycolipidomics.

Masaaki Matsubara1,2, Mayumi Ishihara1,3, Michael Tiemeyer1

  • 1Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602 USA.

BBA Advances
|June 9, 2025
PubMed
Summary
This summary is machine-generated.

We developed DANGO, a computational tool for automated glycosphingolipid annotation. DANGO analyzes both glycan and lipid structures from mass spectrometry data, improving glycolipidomic analysis reliability and speed.

Keywords:
DANGOFree softwareGlycolipidomicsGlycosphingolipidMass spectrometryMass spectrometry data processing

More Related Videos

Quantitative Analysis of the Cellular Lipidome of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry
08:56

Quantitative Analysis of the Cellular Lipidome of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry

Published on: March 8, 2020

7.3K
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
10:59

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Published on: February 7, 2025

931

Related Experiment Videos

Last Updated: Jul 11, 2026

Mass Spectrometric Analysis of Glycosphingolipid Antigens
13:09

Mass Spectrometric Analysis of Glycosphingolipid Antigens

Published on: April 16, 2013

16.5K
Quantitative Analysis of the Cellular Lipidome of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry
08:56

Quantitative Analysis of the Cellular Lipidome of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry

Published on: March 8, 2020

7.3K
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
10:59

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

Published on: February 7, 2025

931

Area of Science:

  • Glycomics
  • Computational Biology
  • Mass Spectrometry

Background:

  • Glycosphingolipids are crucial for eukaryotic cell functions, exhibiting structural diversity in their glycan and lipid components.
  • Existing computational tools often focus on glycan analysis, with limited integration of dynamic lipid composition.
  • Automated annotation tools that consider both glycan and lipid moieties are needed for comprehensive glycolipidomic studies.

Purpose of the Study:

  • To develop an automated computational tool, DANGO (Data ANnotation system for GlycolipidOmics), for annotating mass spectrometry data of glycosphingolipids.
  • To integrate analysis of both glycan and lipid (ceramide) structures within a single platform.
  • To enhance the reliability and efficiency of glycosphingolipid structural annotation.

Main Methods:

  • Developed DANGO, a computational tool extending GRITS Toolbox, for automated annotation of glycolipidomic datasets.
  • Utilized a glycosphingolipid database with curated or user-defined glycan and ceramide collections for annotation.
  • Implemented a novel filter algorithm to reduce false positives and improve computational efficiency.

Main Results:

  • DANGO enables automated annotation of both glycan and lipid moieties in glycosphingolipids from mass spectrometry data.
  • The tool integrates with GRITS Toolbox, offering display routines for organized data and metadata annotation.
  • A novel filter algorithm significantly enhances reliability and reduces computation time for structural annotation.

Conclusions:

  • DANGO provides an automated and efficient solution for the structural annotation of glycosphingolipids.
  • The tool facilitates comprehensive analysis by considering both glycan and lipid diversity.
  • DANGO streamlines the previously labor-intensive manual annotation process, enhancing glycolipidomic data interpretation.